Copaxone

Teva scoffs at whistleblowers' evidence in bid to dismiss kickbacks case
Teva scoffs at whistleblowers' evidence in bid to dismiss kickbacks case
Fierce Pharma
Teva Pharmaceutical
Copaxone
Azilect
kickbacks
generics
whistleblowers
Flag link:
Teva stock drops 4.5% in spite of Q2 profit beat, revenue match
Teva stock drops 4.5% in spite of Q2 profit beat, revenue match
Marketwatch
Teva Pharmaceutical
earnings
Copaxone
Flag link:
A Look at Teva’s Earnings Estimates ahead of Q2 Results
A Look at Teva’s Earnings Estimates ahead of Q2 Results
Market Realist
Teva Pharmaceutical
earnings
Copaxone
Flag link:
Will Mylan’s big Copaxone price break force Teva’s hand? Clients are pushing already
Will Mylan’s big Copaxone price break force Teva’s hand? Clients are pushing already
Fierce Pharma
Mylan Labs
Copaxone
generics
Teva Pharmaceuticals
MS
drug pricing
Flag link:
Mylan decimates the list price of its Copaxone copy. But why?
Mylan decimates the list price of its Copaxone copy. But why?
Fierce Pharma
Mylan
drug pricing
Copaxone
Flag link:
5 Best-Selling Orphan Drugs in the U.S.
5 Best-Selling Orphan Drugs in the U.S.
Motley Fool
orphan drugs
Celgene
Revlimid
Roche
Rituxan
Teva Pharmaceutical
Copaxone
Opdivo
Bristol-Myers Squibb
Merck
Keytruda
Flag link:
FDA Form 483 shows Pfizer repeating same mistakes at troubled fill-finish plant
FDA Form 483 shows Pfizer repeating same mistakes at troubled fill-finish plant
Fierce Pharma
FDA
Pfizer
drug manufacturing
Copaxone
generics
Flag link:
Novartis, Momenta grab a delayed FDA OK for blockbuster Copaxone knockoff
Novartis, Momenta grab a delayed FDA OK for blockbuster Copaxone knockoff
Endpoints
Novartis
Momenta Pharmaceuticals
FDA
Copaxone
Teva Pharmaceutical
Glatopa
MS
multiple sclerosis
Flag link:
Will Teva Pharmaceutical's Pain Be Mylan's Gain?
Will Teva Pharmaceutical's Pain Be Mylan's Gain?
Motley Fool
Teva Pharmaceutical
Mylan Labs
Copaxone
generics
MS
multiple sclerosis
Flag link:
Teva's Turnarond: Is It Ever Or Never?
Teva's Turnarond: Is It Ever Or Never?
Forbes
Teva Pharmaceutical
Copaxone
migraines
fremanezumab
Flag link:
Pfizer's manufacturing fix clears path for Momenta's Copaxone generic
Pfizer's manufacturing fix clears path for Momenta's Copaxone generic
Biopharma Dive
Pfizer
drug manufacturing
generics
Momenta Pharmaceuticals
Copaxone
Novartis
Flag link:
Look out, Teva: Mylan's Copaxone copy has already captured serious share
Look out, Teva: Mylan's Copaxone copy has already captured serious share
Fierce Pharma
Teva Pharmaceutical
Mylan Labs
Copaxone
generics
MS
multiple sclerosis
Flag link:
Mylan: Bad Earnings, Good News?
Mylan: Bad Earnings, Good News?
Barron's
Mylan Labs
earnings
Copaxone
Teva Pharmaceutical
Flag link:
Teva scrambles to match 30% Copaxone discounts from Mylan's knockoff: analyst
Teva scrambles to match 30% Copaxone discounts from Mylan's knockoff: analyst
Fierce Pharma
Teva Pharmaceutical
Mylan Labs
Copaxone
drug discounts
generics
Flag link:
Hard times for Teva Pharmaceutical
Hard times for Teva Pharmaceutical
GoinPharma
Teva Pharmaceutical
Copaxone
Kåre Schultz
Flag link:
FDA offers surprise OK for Mylan’s Copaxone knockoffs, slamming Teva
FDA offers surprise OK for Mylan’s Copaxone knockoffs, slamming Teva
Endpoints
FDA
Mylan Labs
Copaxone
Teva Pharmaceutical
MS
multiple sclerosis
Flag link:
Mylan points finger at FDA for failure to win nods on Advair, Copaxone copies
Mylan points finger at FDA for failure to win nods on Advair, Copaxone copies
Fierce Pharma
Mylan Labs
FDA
Advair
Copaxone
generics
Teva Pharmaceutical
GSK
Flag link:
Mylan's Copaxone copy could face another hold-up with FDA info request
Mylan's Copaxone copy could face another hold-up with FDA info request
Fierce Pharma
Mylan
Copaxone
FDA
generics
Teva Pharmaceutical
MS
multiple sclerosis
Flag link:
Troubled Teva’s successor to Copaxone just failed a big PhIII test for multiple sclerosis
Troubled Teva’s successor to Copaxone just failed a big PhIII test for multiple sclerosis
Endpoints
Teva Pharmaceutical
Copaxone
MS
multiple sclerosis
laquinimod
Active Biotech
Flag link:
Teva Receives Positive Outcome for COPAXONE® 40 mg/ml 3 Times Weekly Label in Europe
Teva Receives Positive Outcome for COPAXONE® 40 mg/ml 3 Times Weekly Label in Europe
Yahoo
Teva
Copaxone
Europe
MS
multiple sclerosis
Flag link:

Pages